Giesing Dennis H 4
4 · Immunome Inc. · Filed Mar 29, 2021
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Giesing Dennis H
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-25+125,000→ 125,000 totalExercise: $31.83Exp: 2031-03-24→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on March 23, 2022, and the remaining 75% of shares subject to the option shall vest in equal monthly installments for the 36 months thereafter.